Protein Binding - Neonatal Disorders

What is Protein Binding?

Protein binding refers to the process by which drugs attach to proteins within the blood. In pediatrics, this concept is crucial because it influences the drug's distribution, efficacy, and elimination in a child's body.

Why is Protein Binding Important in Pediatrics?

In pediatric patients, the physiological factors affecting protein binding can be significantly different from adults. These factors include levels of plasma proteins, age-related differences in protein structure, and the presence of competing endogenous substances.

How Does Age Affect Protein Binding?

Neonates and infants have lower levels of plasma proteins such as albumin and alpha-1-acid glycoprotein. This reduced protein concentration can lead to higher free drug levels, potentially increasing the risk of drug toxicity. With age, protein levels gradually reach adult values, altering the drug binding dynamics.

What Are the Clinical Implications?

Understanding protein binding in pediatric patients is essential for appropriate drug dosing. For instance, highly protein-bound drugs may require lower doses in neonates to avoid toxicity. Conversely, as children grow, adjustments in dosing may be necessary to maintain therapeutic effectiveness.

How Do Disease States Influence Protein Binding?

Certain pediatric conditions, such as liver disease, malnutrition, and renal impairment, can alter protein levels and binding capacity. For example, liver disease can decrease albumin production, leading to higher free drug concentrations and enhanced drug effects or toxicity.

What Role Do Genetic Factors Play?

Genetic polymorphisms can affect the structure and function of plasma proteins, influencing how drugs bind. This variability can lead to differences in drug response among pediatric patients, making personalized medicine an important consideration.

Are There Differences Between Drug Types?

Yes, the degree of protein binding varies among different drugs. Drugs that are highly protein-bound (>90%) are more affected by changes in protein levels, while those with low binding (

Relevant Publications

Structural Maintenance of Chromosomes Complexes.

Issue Release: 2025

Approaching Pharmacological Space: Events and Components.

Issue Release: 2025

Sequence Design for RNA-RNA Interactions.

Issue Release: 2025

14-3-3 Family of Proteins: Biological Implications, Molecular Interactions, and Potential Intervention in Cancer, Virus and Neurodegeneration Disorders.

Issue Release: 2024

Discovery of GPR84 Fluorogenic Probes Based on a Novel Antagonist for GPR84 Bioimaging.

Issue Release: 2024

Molecular insight into the potential functional role of pseudoenzyme GFOD1 via interaction with NKIRAS2.

Issue Release: 2024

Dihydromyricetin ameliorates diabetic renal fibrosis via regulating SphK1 to suppress the activation of NF-κB pathway.

Issue Release: 2024

Inflammatory myofibroblastic tumor from molecular diagnostics to current treatment.

Issue Release: 2024

RhoB plays a central role in hyperosmolarity-induced cell shrinkage in renal cells.

Issue Release: 2024

GNL3L exhibits pro-tumor activities via NF-κB pathway as a poor prognostic factor in acute myeloid leukemia.

Issue Release: 2024

G protein pathway suppressor 2 suppresses aerobic glycolysis through RACK1-mediated HIF-1α degradation in breast cancer.

Issue Release: 2024

The fully reduced terminal oxidase bd-I isolated from Escherichia coli binds cyanide.

Issue Release: 2024

Kinetic and structural characterization of NUDT15 and NUDT18 as catalysts of isoprene pyrophosphate hydrolysis.

Issue Release: 2024

Tumoral EIF4EBP1 regulates the crosstalk between tumor-associated macrophages and tumor cells in MRTK.

Issue Release: 2024

Integrating network pharmacology and animal experimental validation to investigate the action mechanism of oleanolic acid in obesity.

Issue Release: 2024

IGF2BP3/NCBP1 complex inhibits renal tubular senescence through regulation of CDK6 mRNA stability.

Issue Release: 2024

Site-Specific Acetylation of the Transcription Factor Protein Max Modulates Its DNA Binding Activity.

Issue Release: 2024

Value of Vitamin D Metabolite Ratios in 3 Patients as Diagnostic Criteria to Assess Vitamin D Status.

Issue Release: 2024

REEP4 as Potential Biomarker Associated with Predictive Prognosis and Immune Response in Kidney Clear Cell Carcinoma.

Issue Release: 2024

Cinnamaldehyde targets SarA to enhance β-lactam antibiotic activity against methicillin-resistant .

Issue Release: 2024

How Does Nutrition Impact Infection Risk?

What Alternatives Exist for Malaria Prevention and Treatment?

What is Macrocephaly?

What are the Benefits of BDG?

How Can Pediatricians Support Physical Activity in Children?

How Should Bee Stings Be Treated?

What Types of Helmets Are Available?

What are Perinatal Risks?

What are the Challenges in Pediatric Audits?

What Should Be the Immediate Actions?

Partnered Content Networks

Relevant Topics